Bayer HIV-1 IND Study: Background

• IND filed with FDA August, 1999

• Shared filing with Roche Molecular Systems

• Roche AmpliscreenTM microwell plate method

• Testing initiated October 1999

• 96-sample minipools

• Nucleic acid extraction from minipools shared with HCV NAT screening

*

Previous slide

Next slide

Back to first slide

View graphic version